News Center
Home > News Center > Content Pages
Type 1 Diabetes Treatment Funded by California Stem Cell Agency Cleared To Begin Clinical Trial

Type 1 Diabetes Treatment Funded by California Stem Cell Agency Cleared To Begin Clinical Trial

San Francisco, CA – ViaCyte Inc., a regenerative medicine company headquartered in San Diego, has been given approval to begin a clinical trial for a promising treatment for type 1 diabetes, a program that is funded by the California Institute for Regenerative Medicine (CIRM), California’s stem cell agency.

The Food and Drug Administration (FDA) gave ViaCyte the go-ahead after reviewing their application for an Investigational New Drug application (“IND”). The phase 1/2 clinical trial will see if their VC-01™ product candidate is safe and shows preliminary evidence of being beneficial to patients.

“CIRM was created to help develop stem cell treatments for diseases that are currently incurable with traditional approaches,” says C. Randal Mills, Ph.D., the President and CEO of the stem cell agency. “Working in collaboration with CIRM for the past 6 years, ViaCyte has developed a particularly novel approach to overcome the challenges of treating type 1 diabetes.  Anytime a product, particularly one as innovative as this one, progresses from the lab and into clinical trials it’s very encouraging news, particularly for the patients suffering from the disease.”

“The ViaCyte team is very pleased to have received FDA acceptance for our clinical trial protocol and look forward to initiating this study shortly,” said Paul Laikind, Ph.D., President and CEO of ViaCyte.  “The commencement of this trial marks a significant milestone that could not have been achieved without the support we have received and continue to receive from CIRM.”

To read the rest of the article, CLICK HERE

>> Returns a list of pages
My Comments

0  Comments Currently

Related Category
Promotion Products
  • Partners
  • Links
USCAP  |   CAP  |   IAP  |   TPIS  |   ASC  |   CAP-ACP  |   ASIP  |   AMP  |   ASCP  |   CAPA  |  
Home  |  News  |  Journals  |  Cases  |  Lectures  |  Experts  |  Telepath  |  Research  |  Conferences  |  Job_Position  |  Books  |  Sponsors
2009-2015 All Rights Reserved GoPath Diagnostics, LLC.